Primary Sclerosing Cholangitis
Top Cited Papers
- 22 September 2016
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 375 (12), 1161-1170
- https://doi.org/10.1056/nejmra1506330
Abstract
This review summarizes the current understanding of primary sclerosing cholangitis, a persistent, progressive disease for which there is no definitive therapy. The authors describe the pathogenesis and management of this condition.This publication has 74 references indexed in Scilit:
- Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and ManagementGastroenterology, 2013
- Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk lociJournal of Hepatology, 2012
- Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotypeProceedings of the National Academy of Sciences of the United States of America, 2011
- Cholangiocyte N-Ras Protein Mediates Lipopolysaccharide-induced Interleukin 6 Secretion and ProliferationJournal of Biological Chemistry, 2011
- Cancer surveillance in patients with primary sclerosing cholangitisHepatology, 2011
- Bone Disease in Patients With Primary Sclerosing CholangitisGastroenterology, 2011
- Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitisDigestive and Liver Disease, 2011
- Gut Homing Receptors on CD8 T Cells Are Retinoic Acid Dependent and Not Maintained by Liver Dendritic or Stellate CellsGastroenterology, 2009
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitisHepatology, 2009
- Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− miceHepatology, 2009